SCHEMBL19634096

SCHEMBL19634096

COc1ccc(CN(Sc2c(F)cc(OC3CCN(C(=O)OC(C)(C)C)CC3)c(Cl)c2F)c2nccs2)c(OC)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.39
GPR119 Q8TDV5 7/20 0.38
PDE4B Q07343 3/20 0.38
PDE4A P27815 2/20 0.38
PDE4C Q08493 2/20 0.38
PDE4D Q08499 2/20 0.38
EPHX2 P34913 1/20 0.37
STS P08842 1/20 0.36
CACNB4 O00305 1/20 0.36
CACNA1A O00555 1/20 0.36
CACNA1G O43497 1/20 0.36
CACNG3 O60359 1/20 0.36
CACNA1F O60840 1/20 0.36
CACNA1H O95180 1/20 0.36
CACNB3 P54284 1/20 0.36
CACNA2D1 P54289 1/20 0.36
CACNG7 P62955 1/20 0.36
CACNA1B Q00975 1/20 0.36
CACNA1D Q01668 1/20 0.36
CACNB1 Q02641 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19634261 0.93 MAPT (0.39) MAPTGPR119PDE4BPDE4APDE4C
SCHEMBL19634139 0.89 MAPT (0.39) MAPTGPR119PDE4BPDE4APDE4C
SCHEMBL19634012 0.86 PDE4B (0.41) MAPTGPR119PDE4BPDE4APDE4C
SCHEMBL19613246 0.85 GPR119 (0.41) MAPTGPR119PDE4BPDE4APDE4C
SCHEMBL22590192 0.82 GPR119 (0.44) MAPTGPR119PDE4BPDE4APDE4C
SCHEMBL19631616 0.82 PIK3CD (0.38) MAPTGPR119PDE4BPDE4APDE4C
SCHEMBL19627660 0.80 GPR119 (0.39) MAPTGPR119PDE4BPDE4APDE4C
SCHEMBL19614227 0.80 SCN1A (0.43) MAPTGPR119PDE4BPDE4APDE4C
SCHEMBL19634256 0.79 P2RX3 (0.37) MAPTPDE4BPDE4APDE4CPDE4D
SCHEMBL19634121 0.79 MEN1 (0.36) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017201468-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2017-11-23 WO disclosed